Brand Name: Rover Product Name: Mobile X-ray System Model/Catalog Number: MXU-RV35 Product Description: Rover Mobile ... — FDA record Z-1579-2025

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 28, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Brand Name: Rover Product Name: Mobile X-ray System Model/Catalog Number: MXU-RV35 Product Description: Rover Mobile X-rays System ("Rover") is a mobile imaging system that incorporates a self-contained X-ray generator, imaging display and software for acquiring medical diagnostic images outside a standard X-ray room. It is designed specifically for Digital Radiography (DR) with vendor-supported detectors. The Rover is designed to perform radiographic X-ray examinations for disease/injury detection, diagnosis, medical and surgical treatment planning, and therapy monitoring, where patient condition contraindicates transport to a fixed X-ray unit The Rover can be used on pediatric and adult patients, in all patient treatment areas Component: N/A
Reason
Potential for early life x-ray tube failure for mobile x-ray system due to excessive thermal load on the anode.
Classification
Class II
Recalling firm
Micro-X Ltd.
Quantity
20 units
Agency-reported status
Ongoing
Source record identifier
Z-1579-2025

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilitySerial Number/UDI: MSN0348 (01)09357123000037(11)230123(21)00348; MSN0349 (01)09357123000037(11)230209(21)00349; MSN0351 (01)09357123000037(11)230413(21)00351; MSN0359 (01)09357123000037(11)231130(21)00359; MSN0361 (01)09357123000037(11)230503(21)00361; MSN0365 (01)09357123000037(11)230510(21)00365; MSN0391 (01)09357123000037(11)230929(21)00391; MSN0406 (01)09357123000037(11)240301(21)00406; MSN0416 (01)09357123000037(11)240429(21)00416; MSN0419 (01)09357123000037(11)240628(21)00419; MSN0428 (01)09357123000037(11)240823(21)00428; MSN0429 (01)09357123000037(11)240823(21)00429; MSN0430 (01)09357123000037(11)240824(21)00430; MSN0431 (01)09357123000037(11)240826(21)00431; MSN0432 (01)09357123000037(11)241108(21)00432; MSN0434 (01)09357123000037(11)241115(21)00434; MSN0435 (01)09357123000037(11)241118(21)00435; MSN0436 (01)09357123000037(11)241122(21)00436; MSN0437 (01)09357123000037(11)241125(21)00437; MSN0438 (01)09357123000037(11)250114(21)00438

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of CA, NJ, and Puerto Rico (US territory).

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Apr 23, 2025
Recall initiation date
Mar 28, 2025
Center classification date
Apr 16, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records